| Dr Madeleine Alva Mathis, PHD | |
|
2801 Cornhusker Hwy, Suite 201, Lincoln, NE 68504-1545 | |
| (402) 473-2808 | |
| (402) 466-5085 |
| Full Name | Dr Madeleine Alva Mathis |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 2801 Cornhusker Hwy, Lincoln, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164453031 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 478 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Madeleine Alva Mathis, PHD 2801 Cornhusker Hwy, Suite 201, Lincoln, NE 68504-1545 Ph: (402) 473-2808 | Dr Madeleine Alva Mathis, PHD 2801 Cornhusker Hwy, Suite 201, Lincoln, NE 68504-1545 Ph: (402) 473-2808 |
News Archive
The University of Kansas has earned funding to launch a center dedicated to connecting researchers, educators and higher education faculty across the country to improve the use of technology in special education.
The issue is figuring prominently in races in Colorado and New Hampshire, where Democratic incumbents are highlighting their differences with Republican challengers.
Cell Therapeutics, Inc. today announced that the North Central Cancer Treatment Group ("NCCTG") plans to conduct a Phase II study of brostallicin in combination with cisplatin in patients with metastatic triple-negative breast ("mTNBC") cancer, defined by tumors lacking expression of estrogen, progesterone receptors and without over-expression of HER2. Additionally, the majority of breast cancers that are associated with the susceptibility mutation (BRCA1) are of the triple-negative type.
IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that they will be presenting positive interim Phase I clinical results for their H5N1 Avian Influenza VLP vaccine candidate "H5N1 vaccine" at the World Vaccine Congress.
› Verified 4 days ago
Dr. Thomas Robert Cardwell, PSYCHOLOGIST Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2300 S 16th St, Lincoln, NE 68502 Phone: 402-481-5454 | |
Dr. Gail Maureen Ihle, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 650 J St, St 403, Lincoln, NE 68508 Phone: 402-435-1313 Fax: 402-435-5056 | |
Dr. Corrie A Davies, P.H.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8201 Northwoods Dr, Lincoln, NE 68505 Phone: 402-465-5600 Fax: 402-437-6074 | |
Dr. Amber M Zeisler, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4535 Normal Blvd, Ste 295, Lincoln, NE 68506 Phone: 402-853-6686 | |
Molly Marie Burns, PSY.D Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2222 S 16th St, Suite 210, Lincoln, NE 68502 Phone: 402-328-8300 Fax: 402-328-8383 | |
Patricia R Cerda-lizarraga, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1500 U St, Lincoln, NE 68588 Phone: 402-472-5000 Fax: 402-472-8010 | |
Laurel B Van Ham, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 4600 Valley Road, Suite 200, Lincoln, NE 68510 Phone: 402-483-4571 Fax: 402-483-5079 |